Cartesian Therapeutics, Inc. (RNAC)
NGM – Real Time Price. Currency in USD
8.79
+0.20 (2.39%)
Market open: Aug 12, 2026, 9:44 AM EDT
8.59
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
8.79
+0.20 (2.39%)
Market open: Aug 12, 2026, 9:44 AM EDT
8.59
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $147.6M significantly exceed its total debt $63.9M, ensuring strong financial flexibility
Total current assets $153.6M exceed Total current liabilities $20.6M, highlighting excellent liquidity
Debt-to-equity ratio (-0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-34.2x) is dangerously low, suggesting debt repayment risks
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.48 | 6.05 | 10 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.20 | 1.04 | 8.0 | |
| Interest coverage | -34.22 | -16.91 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 111M | 26M | 39M | 3M | 1M |
| Gross Profit | 109M | 24M | 38M | -162K | -352K |
| Operating Income | 15M | -86M | -31M | -87M | -99M |
| Net Income | 35M | -257M | -77M | -130M | -154M |
| EBITDA | 17M | -85M | -29M | -84M | -68M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -66.81 | 27.49 | 5.5 |
| Next quarter | -70.08 | 68.95 | 5.5 |
| Current year | -86.44 | 37.08 | 5.5 |
| Next year | -24.66 | -28.76 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | 135.02 | 131.51 | -21.73 | 5.5 |
| Y/Y | -99.99 | -13.62 | -7.99 | 8.36 | 2.3 |
| 3y average | -39.88 | -275.17 | -237.48 | -54.16 | 1.0 |
| 5y average | 64.63 | -105.01 | -87.14 | -79.26 | 3.3 |
| Weighted average score | 3.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |